May
13
2025
Phase 3 Development Plan for Evenamide as Add-On Therapy for Treatment-Resistant Schizophrenia – Psychiatric Times
Phase 3 Development Plan for Evenamide as Add-On Therapy for Treatment-Resistant Schizophrenia Psychiatric Times
